FISH OIL CARDIAC DRUG - AN OVERVIEW

The approval reverses decades of combined effects for fish-oil-dependent drugs and will lead to Vascepa remaining prescribed to an incredible number of individuals, potentially causing a windfall for that drug’s maker, Amarin Prescription drugs, which sells no other merchandise.The new approval greatly expands the likely pool of patients, because